News
Trump Administration Releases New COVID-19 Vaccine Plan: What to Know
In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
Live Science on MSN1d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The World Health Organisation said on Tuesday that circulating vaccine-derived poliovirus type 2 (cVDPV2) had been detected ...
Data shows that the two-dose measles vaccine is 97% effective at preventing measles and experts say protection doesn’t wane.
A vaccine that helps people overcome cocaine addiction has shown signs of being safe and effective in a small trial ...
Vaccine maker’s £1bn UK investment to create ‘hundreds of high-skilled jobs’ - BioNTech developed mRNA vaccines, and cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback